Pharma & Biotech Global Week in Review 21 Dec 2011 from IP Think Tank

Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.

 

Highlights this week included:

EU: Further SPC granting guidelines from the CJEU – Yeda, Queensland, Daiichi Sankyo (EPLAW) (The SPC Blog)

 

Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.

 

General

WHO expert group to recommend binding R&D treaty negotiation (IP Watch)

EU: Further SPC granting guidelines from the CJEU – Yeda, Queensland, Daiichi Sankyo (EPLAW) (The SPC Blog)

Spain: Supreme Court rejects requesting opinion from ECJ on TRIPS (Kluwer Patent Blog)

US: Pleading of inequitable conduct intent to deceive requires only facts from which it is plausible: Human Genome Sciences Inc., et. al. v. Genentech Inc., et. al. (Docket Report)

US: Where do processes of nature end and processes of human invention begin? (Patently-O)

US: Time spent asking questions in Mayo v Prometheus (Patently-O)

US: Will patents become irrelevant in a biosimilars future? (Patent Docs)

US: Revelations: FDA’s perspective on drugs marketed pursuant to a pending DESI proceeding and the Unapproved Drugs CPG (FDA Law Blog)

US: GAO report finds that FDA needs increased authority to address shortages (FDA Law Blog)

US: Medical Device Patient Safety Act introduced in the Senate; Bill would allow for recall tracking and conditional clearances (FDA Law Blog)

 

Products

Abraxane (Paclitaxel) – US: Cephalon files patent infringement suit against Celgene over its manufacture and sale of Abraxane (Patent Docs)

Doribax (Doripenem) – US: Janssen files patent infringement complaint against Sandoz in reponse to Para IV challenge (Patent Docs)

Doryx (Doxycycline)  – US: Federal Circuit vacates preliminary injunction entered against Mylan in Doxycycline case: Warner Chilcott v Mylan (Orange Book Blog)

Esomeprazole – Norway: Borgarting Court of Appeal dismisses Krka’s appeal against decision granting AstraZeneca a preliminary injunction (Kluwer Patent Blog)

Folbic / Foltx (Vitamins B12, B6 and folic acid) – US PAMLAB files patent infringement suit against Macoven over manufacture and sale of products represented to be substitutable for Foltx or Folbic (Patent Docs)

Generess Fe (Norethindrone, Ethinyl estradiol) – US: Warner Chilcott files patent infringement suit against Lupin in response to Para IV challenge (Patent Docs)

Glucotrol (Glipizide) – US: Alza Corp files patent infringement suit against Mylan in response to Para IV certification filing (Patent Docs)

Humira (Adalimumab) – UK: Experiments in the Patents County Court: when are they allowed?: Liversedge v Owen Mumford Ltd & Anor (PatLit)

Intuniv (Guanfacine) – US: Shire files patent infringement complaint against Mylan in response to ANDA filing (Patent Docs)

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: